Cancer can impact anyone, anywhere. By 2050, global cancer cases are expected to rise by 75%. That’s why we’re pushing the boundaries of science to develop next-generation targeted therapies that have the potential to truly change the lives of people living with the disease. #ESMO25 #OncologyInspired http://spr.ly/6040AL9YI
More Relevant Posts
-
Since 2020, patients have gained access to more than 30 new cancer treatments thanks to technologies funded by the National Cancer Institute (NCI) that earned 53 regulatory approvals. These aren’t just approvals; they’re lifelines for people in need. #whatsatstake #cancerresearch #pacr
-
-
Join us at #ESMO25 to learn more about our latest research in #NSCLC. We are presenting long-term outcomes data along with new analyses on treatment sequencing that may help inform clinical practice. Sharing these informative data are just one way we show our commitment to advancing science and improving outcomes for those affected by lung cancer worldwide. #LungCancer #HCPsOnly
ESMO 2025: Long-Term Data in NSCLC
-
Join us at #ESMO25 to learn more about our latest research in #NSCLC. We are presenting long-term outcomes data along with new analyses on treatment sequencing that may help inform clinical practice. Sharing these informative data are just one way we show our commitment to advancing science and improving outcomes for those affected by lung cancer worldwide. #LungCancer #HCPsOnly
ESMO 2025: Long-Term Data in NSCLC
-
Breast cancer continues to be the leading cause of cancer-related deaths for women worldwide, with more than 3 million diagnoses estimated each year by 2040. I’m proud to be part of a team at AstraZeneca that’s working to change that every day. By advancing science, innovating medicines and technology, we’re pushing towards a future where breast cancer can be eliminated as a cause of death. Together, across the healthcare community, we can break down barriers to better cancer care. Learn more here: https://lnkd.in/eURC3WUn #BreastCancerAwarenessMonth
-
Breast cancer continues to be the leading cause of cancer-related deaths for women worldwide, with more than 3 million diagnoses estimated each year by 2040. I’m proud to be part of a team at AstraZeneca that’s working to change that every day. By advancing science, innovating medicines and technology, we’re pushing towards a future where breast cancer can be eliminated as a cause of death. Together, across the healthcare community, we can break down barriers to better cancer care. Learn more here: https://lnkd.in/eCG464iF #BreastCancerAwarenessMonth
-
Breast cancer continues to be the leading cause of cancer-related deaths for women worldwide, with more than 3 million diagnoses estimated each year by 2040. I’m proud to be part of a team at AstraZeneca that’s working to change that every day. By advancing science, innovating medicines and technology, we’re pushing towards a future where breast cancer can be eliminated as a cause of death. Together, across the healthcare community, we can break down barriers to better cancer care. Learn more here: https://lnkd.in/gUiZbZKE #BreastCancerAwarenessMonth
-
Breast cancer continues to be the leading cause of cancer-related deaths for women worldwide, with more than 3 million diagnoses estimated each year by 2040. I’m proud to be part of a team at AstraZeneca that’s working to change that every day. By advancing science, innovating medicines and technology, we’re pushing towards a future where breast cancer can be eliminated as a cause of death. Together, across the healthcare community, we can break down barriers to better cancer care. Learn more here: https://lnkd.in/eb2WdiRd #BreastCancerAwarenessMonth
-
Senior Global Talent Researcher at AstraZeneca: Searching for the best talent to deliver our strong and varied pipeline.
Breast cancer continues to be the leading cause of cancer-related deaths for women worldwide, with more than 3 million diagnoses estimated each year by 2040. I’m proud to be part of a team at AstraZeneca that’s working to change that every day. By advancing science, innovating medicines and technology, we’re pushing towards a future where breast cancer can be eliminated as a cause of death. Together, across the healthcare community, we can break down barriers to better cancer care. Learn more here: https://lnkd.in/dmiANtGW #BreastCancerAwarenessMonth
-
At #ESMO25, we're shedding light on the critical unmet needs in HER2-mutant non-small cell lung cancer (NSCLC). This aggressive form of cancer can affect younger, non-smoking women, with limited targeted treatment options. Our focus is on pioneering precise and personalized healthcare solutions where unmet needs are highest. #OncologyInspired #HealthforAll #ESMO25
-
Director, Business Partnering Communications for Global IT (Global Corporate Affairs) at AstraZeneca
Breast cancer continues to be the leading cause of cancer-related deaths for women worldwide, with more than 3 million diagnoses estimated each year by 2040. I’m proud to be part of a team at AstraZeneca that’s working to change that every day. By advancing science, innovating medicines and technology, we’re pushing towards a future where breast cancer can be eliminated as a cause of death. Together, across the healthcare community, we can break down barriers to better cancer care. Learn more here: https://lnkd.in/gGpicJDp #BreastCancerAwarenessMonth
More from this author
Explore content categories
- Career
- Productivity
- Finance
- Soft Skills & Emotional Intelligence
- Project Management
- Education
- Technology
- Leadership
- Ecommerce
- User Experience
- Recruitment & HR
- Customer Experience
- Real Estate
- Marketing
- Sales
- Retail & Merchandising
- Science
- Supply Chain Management
- Future Of Work
- Consulting
- Writing
- Economics
- Artificial Intelligence
- Employee Experience
- Workplace Trends
- Fundraising
- Networking
- Corporate Social Responsibility
- Negotiation
- Communication
- Engineering
- Hospitality & Tourism
- Business Strategy
- Change Management
- Organizational Culture
- Design
- Innovation
- Event Planning
- Training & Development
Clinical Strategist LATAM | Rare & Ultra-Rare Diseases | AI-Driven Medical Affairs | Precision Intelligence for Pharma | Rewriting the Clinical Code for Rare Innovation
4dBehind these projections, rare and ultra-rare cancers remain underrepresented. Precision oncology must include invisible subtypes—those that never reach ESMO statistics but carry devastating diagnostic delays, especially in underserved regions like LATAM.